Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559).
Hotchkiss RS, Colston E, Yende S, Angus DC, Moldawer LL, Crouser ED, Martin GS, Coopersmith CM, Brakenridge S, Mayr FB, Park PK, Ye J, Catlett IM, Girgis IG, Grasela DM.
Hotchkiss RS, et al.
Crit Care Med. 2019 May;47(5):632-642. doi: 10.1097/CCM.0000000000003685.
Crit Care Med. 2019.
PMID: 30747773
Free PMC article.
Clinical Trial.